
Please try another search
Zomedica (ZOM) and Elanco (ELAN) are companies within the pet healthcare industry. While one is in the development stage the other is an established player. The pet industry all over the world continues to expand making the two companies enticing bets for 2021 and beyond but which one is a better buy now?.Several industries have benefited from the COVID-19 pandemic as people were confined to their homes and entertainment options were limited. Companies part of the e-commerce, streaming, gaming, and streaming vertical saw a massive uptick in consumer demand.
Another space that significantly benefited from the coronavirus lockdown was the pet industry. More than 11 million U.S. households were estimated to have gotten a new pet during the pandemic. This trend acted as a secular driver for pet healthcare companies.
Here, we take a look at two companies part of the pet healthcare industry, Zomedica (ZOM) and Elanco (ELAN), to analyze which is a better stock right now.
By Brent Lang LOS ANGELES (Variety.com) - "Bullet Train," a John Wick-ian romp with Brad Pitt in the aisle seat, arrived in theaters with a $30.1 million opening weekend. That's...
Investing.com – Saudi Arabia stocks were lower after the close on Sunday, as losses in the Hotels & Tourism, Petrochemicals and Financial Services sectors led shares lower. At the...
By Saqib Iqbal Ahmed NEW YORK (Reuters) -A rally in U.S. stocks that has powered on despite skepticism from Wall St faces a reality check in the coming week, as key inflation data...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.